Title |
Syndromes Predisposing to Pediatric Central Nervous System Tumors: Lessons Learned and New Promises
|
---|---|
Published in |
Current Neurology and Neuroscience Reports, December 2011
|
DOI | 10.1007/s11910-011-0244-5 |
Pubmed ID | |
Authors |
Anita Villani, David Malkin, Uri Tabori |
Abstract |
Central nervous system (CNS) neoplasms are a leading cause of morbidity and mortality among children with cancer. In contrast to adults, a genetic basis for brain tumors is relatively common in children. A child harboring a germline mutation in a cancer-related gene will be predisposed to develop CNS tumors. These cancer predisposition syndromes are rare but pose overwhelming clinical and psychosocial challenges to families and the treating team. Recent significant advances in our understanding of the biological processes that govern these genetic conditions combined with international efforts to define and treat clinical aspects of these tumors are transforming the lives of these individuals. In this article, we summarize recent progress made for each of the major CNS tumor syndromes. We discuss the biological and clinical relevance of such advances, and suggest a comprehensive approach to a child affected by a predisposition to brain tumors. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 2% |
Canada | 1 | 2% |
Unknown | 40 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 17% |
Student > Doctoral Student | 6 | 14% |
Student > Ph. D. Student | 5 | 12% |
Student > Master | 4 | 10% |
Other | 4 | 10% |
Other | 6 | 14% |
Unknown | 10 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 15 | 36% |
Agricultural and Biological Sciences | 6 | 14% |
Psychology | 4 | 10% |
Biochemistry, Genetics and Molecular Biology | 3 | 7% |
Environmental Science | 1 | 2% |
Other | 2 | 5% |
Unknown | 11 | 26% |